Center for Pharmacognosy and Phytotherapy, Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University College London, 29-39 Brunswick Square, WC1N 1AX London, United Kingdom.
J Ethnopharmacol. 2014 Sep 11;155(2):857-924. doi: 10.1016/j.jep.2014.05.055. Epub 2014 Jun 12.
The prevalence of diabetes is on a steady increase worldwide and it is now identified as one of the main threats to human health in the 21st century. In Nigeria, the use of herbal medicine alone or alongside prescription drugs for its management is quite common. We hereby carry out a review of medicinal plants traditionally used for diabetes management in Nigeria. Based on the available evidence on the species׳ pharmacology and safety, we highlight ways in which their therapeutic potential can be properly harnessed for possible integration into the country׳s healthcare system.
Ethnobotanical information was obtained from a literature search of electronic databases such as Google Scholar, Pubmed and Scopus up to 2013 for publications on medicinal plants used in diabetes management, in which the place of use and/or sample collection was identified as Nigeria. 'Diabetes' and 'Nigeria' were used as keywords for the primary searches; and then 'Plant name - accepted or synonyms', 'Constituents', 'Drug interaction' and/or 'Toxicity' for the secondary searches.
The hypoglycemic effect of over a hundred out of the 115 plants reviewed in this paper is backed by preclinical experimental evidence, either in vivo or in vitro. One-third of the plants have been studied for their mechanism of action, while isolation of the bioactive constituent(s) has been accomplished for twenty three plants. Some plants showed specific organ toxicity, mostly nephrotoxic or hepatotoxic, with direct effects on the levels of some liver function enzymes. Twenty eight plants have been identified as in vitro modulators of P-glycoprotein and/or one or more of the cytochrome P450 enzymes, while eleven plants altered the levels of phase 2 metabolic enzymes, chiefly glutathione, with the potential to alter the pharmacokinetics of co-administered drugs.
This review, therefore, provides a useful resource to enable a thorough assessment of the profile of plants used in diabetes management so as to ensure a more rational use. By anticipating potential toxicities or possible herb-drug interactions, significant risks which would otherwise represent a burden on the country׳s healthcare system can be avoided.
糖尿病的发病率在全球范围内呈稳步上升趋势,现已成为 21 世纪人类健康的主要威胁之一。在尼日利亚,单独使用草药或与处方药一起治疗糖尿病的情况非常普遍。因此,我们对尼日利亚传统上用于治疗糖尿病的药用植物进行了综述。根据有关物种药理学和安全性的现有证据,我们强调了如何适当利用其治疗潜力,以便将其纳入该国的医疗保健系统。
通过对电子数据库(如 Google Scholar、Pubmed 和 Scopus)进行文献检索,获取了 2013 年之前发表的关于用于糖尿病管理的药用植物的民族植物学信息,其中使用地点和/或样本采集地点被确定为尼日利亚。“糖尿病”和“尼日利亚”被用作主要搜索的关键词;然后进行了二次搜索,关键词为“植物名称-接受或同义词”、“成分”、“药物相互作用”和/或“毒性”。
本文综述的 115 种植物中,有超过 100 种植物的降血糖作用得到了临床前实验证据的支持,这些证据包括体内或体外实验。其中三分之一的植物已研究过其作用机制,而 23 种植物已分离出生物活性成分。一些植物表现出特定的器官毒性,主要是肾毒性或肝毒性,直接影响某些肝功能酶的水平。28 种植物已被鉴定为 P-糖蛋白和/或一种或多种细胞色素 P450 酶的体外调节剂,11 种植物改变了 II 相代谢酶的水平,主要是谷胱甘肽,从而可能改变共同给药药物的药代动力学。
因此,本综述为全面评估用于糖尿病管理的植物的应用概况提供了有用的资源,以确保更合理的使用。通过预测潜在的毒性或可能的草药-药物相互作用,可以避免对该国医疗保健系统造成重大风险。